These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8704292)

  • 1. The spectrum of neuroimaging abnormalities in solvent abuse and their clinical correlation.
    Caldemeyer KS; Armstrong SW; George KK; Moran CC; Pascuzzi RM
    J Neuroimaging; 1996 Jul; 6(3):167-73. PubMed ID: 8704292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toluene abuse: physical basis for hypointensity of the basal ganglia on T2-weighted MR images.
    Unger E; Alexander A; Fritz T; Rosenberg N; Dreisbach J
    Radiology; 1994 Nov; 193(2):473-6. PubMed ID: 7972765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cranial MR findings in chronic toluene abuse by inhalation.
    Aydin K; Sencer S; Demir T; Ogel K; Tunaci A; Minareci O
    AJNR Am J Neuroradiol; 2002 Aug; 23(7):1173-9. PubMed ID: 12169477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter changes caused by chronic solvent abuse.
    Yamanouchi N; Okada S; Kodama K; Hirai S; Sekine H; Murakami A; Komatsu N; Sakamoto T; Sato T
    AJNR Am J Neuroradiol; 1995 Sep; 16(8):1643-9. PubMed ID: 7502969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-voxel proton MR spectroscopy in toluene abuse.
    Aydin K; Sencer S; Ogel K; Genchellac H; Demir T; Minareci O
    Magn Reson Imaging; 2003 Sep; 21(7):777-85. PubMed ID: 14559343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature.
    Yücel M; Takagi M; Walterfang M; Lubman DI
    Neurosci Biobehav Rev; 2008 Jul; 32(5):910-26. PubMed ID: 18456329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse.
    Rosenberg NL; Grigsby J; Dreisbach J; Busenbark D; Grigsby P
    J Toxicol Clin Toxicol; 2002; 40(1):21-34. PubMed ID: 11990201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.
    Bakshi R; Dmochowski J; Shaikh ZA; Jacobs L
    J Neurol Sci; 2001 Mar; 185(1):19-26. PubMed ID: 11266686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images.
    Kamran S; Bakshi R
    Neuroradiology; 1998 Aug; 40(8):519-21. PubMed ID: 9763341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging Applications in Chronic Ataxias.
    Mascalchi M; Vella A
    Int Rev Neurobiol; 2018; 143():109-162. PubMed ID: 30473193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of chronic toluene intoxication with abnormal MRI findings: abnormal intensity areas in cerebral white matter, basal ganglia, internal capsule, brain stem and middle cerebellar peduncle].
    Suzuki K; Wakayama Y; Takada H; Okayasu H
    Rinsho Shinkeigaku; 1992 Jan; 32(1):84-7. PubMed ID: 1628443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smaller gray matter volumes in frontal and parietal cortices of solvent abusers correlate with cognitive deficits.
    Aydin K; Kircan S; Sarwar S; Okur O; Balaban E
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1922-8. PubMed ID: 19643925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis.
    Ceccarelli A; Filippi M; Neema M; Arora A; Valsasina P; Rocca MA; Healy BC; Bakshi R
    Mult Scler; 2009 Jun; 15(6):678-86. PubMed ID: 19482861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toluene abuse causes diffuse central nervous system white matter changes.
    Rosenberg NL; Kleinschmidt-DeMasters BK; Davis KA; Dreisbach JN; Hormes JT; Filley CM
    Ann Neurol; 1988 Jun; 23(6):611-4. PubMed ID: 3408242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system effects of chronic toluene abuse--clinical, brainstem evoked response and magnetic resonance imaging studies.
    Rosenberg NL; Spitz MC; Filley CM; Davis KA; Schaumburg HH
    Neurotoxicol Teratol; 1988; 10(5):489-95. PubMed ID: 3247003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
    Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral perfusion impairment in a patient with toluene abuse.
    Ryu YH; Lee JD; Yoon PH; Jeon P; Kim DI; Shin DW
    J Nucl Med; 1998 Apr; 39(4):632-3. PubMed ID: 9544669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic sequelae of chronic solvent vapor abuse.
    Hormes JT; Filley CM; Rosenberg NL
    Neurology; 1986 May; 36(5):698-702. PubMed ID: 3703270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephalopathy due to toluene sniffing. Report of a case with magnetic resonance imaging.
    Ikeda M; Tsukagoshi H
    Eur Neurol; 1990; 30(6):347-9. PubMed ID: 2289514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.